Loading your page…
Hepatitis C, Chronic
Marketing Authorisation Holder: Gilead Sciences Ireland UC
EMA Authorisation: 17/11/2014
INN: ledispavir;sofosbuvir
AI Drug & Interaction Analysis
Free account required
Ask Osler about Harvoni: drug interactions and guideline evidence, with every claim numbered to its source. For reference and learning, not treatment advice.
Medical disclaimer: This information is intended for qualified healthcare professionals. Always verify with the official EMA Summary of Product Characteristics (SmPC) before clinical use.
